Insmed (INSM) Chief Financial Officer Sara Bonstein is stepping down, the company said Monday.
Bonstein will continue in that role through Oct. 30 as the company looks for a new CFO.
Insmed continues to expect 2026 revenue of $1.25 billion to $1.40 billion for Brinsupri and $450 million to $470 million for Arikayce, it said.
The company's shares were down 2.7% in premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.